Division of Cardiology, Department of Internal Medicine, VCU Pauley Heart Center, Virginia Commonwealth University, Richmond, VA 23298-0204, USA.
J Cell Mol Med. 2012 Apr;16(4):950-8. doi: 10.1111/j.1582-4934.2011.01376.x.
Ischaemic post-conditioning (PostC) is a clinically relevant cardioprotective modality that has been confirmed in many species including human. It remains unknown if PostC can still protect heart in Type 2 diabetes, a rapidly growing disease in the world. This study investigated the efficacy of PostC in the leptin receptor-deficient db/db mice, which possess Type 2 diabetic characteristics including obesity, hyperglycaemia and hyperleptinaemia. Adult male C57BL/6J wild-type (WT) and db/db mice were anaesthetized, mechanically ventilated and subjected to left coronary artery occlusion for 30 min. followed by 24 hrs of reperfusion. For the PostC groups, the hearts underwent six cycles of 10 sec. of reperfusion and 10 sec. of re-occlusion at the onset of reperfusion. The mice were sacrificed at the end of 24 hrs reperfusion for infarct size measurement. PostC significantly reduced infarct size in WT mice (n = 6/group; P < 0.05), but not in the db/db mice. To identify alterations in protein expression by PostC, proteomic analyses were performed in the heart samples using two-dimensional differential in-gel electrophoresis with three CyDye labelling, followed by mass spectrometry. The results show that mitochondrial proteins (F(1)-ATPase γ and Echs1) were down-regulated by PostC in WT heart. Such change was absent in the db/db heart. On the other hand, PostC reduced Hsp20 in the diabetic heart. In summary, PostC fails to protect Type 2 diabetic mice against ischaemia-reperfusion injury. The potential protein targets for the loss of PostC may include F(1)-ATPase γ, Echs1 and Hsp20 that could regulate cellular ATP consumption/production and defense response to ischaemic stress.
缺血后处理(PostC)是一种临床相关的心脏保护方式,已在包括人类在内的许多物种中得到证实。目前尚不清楚 PostC 是否仍能保护 2 型糖尿病患者的心脏,2 型糖尿病在世界范围内呈快速增长趋势。本研究旨在探讨 PostC 在瘦素受体缺失的 db/db 小鼠中的疗效,该模型具有肥胖、高血糖和高瘦素血症等 2 型糖尿病特征。成年雄性 C57BL/6J 野生型(WT)和 db/db 小鼠接受麻醉、机械通气,并进行左冠状动脉闭塞 30 分钟,随后再灌注 24 小时。对于 PostC 组,心脏在再灌注开始时经历 6 个循环,每个循环包括 10 秒再灌注和 10 秒再闭塞。在再灌注 24 小时结束时处死小鼠,测量梗死面积。PostC 显著减少 WT 小鼠(每组 n = 6;P < 0.05)的梗死面积,但对 db/db 小鼠无效。为了确定 PostC 引起的蛋白质表达变化,使用二维差异凝胶电泳结合三种 CyDye 标记,对心脏样本进行蛋白质组学分析,然后进行质谱分析。结果表明,线粒体蛋白(F(1)-ATPase γ 和 Echs1)在 WT 心脏中被 PostC 下调,但在 db/db 心脏中没有这种变化。另一方面,PostC 减少了糖尿病心脏中的 Hsp20。总之,PostC 未能保护 2 型糖尿病小鼠免受缺血再灌注损伤。PostC 丧失的潜在蛋白质靶标可能包括 F(1)-ATPase γ、Echs1 和 Hsp20,它们可以调节细胞 ATP 的消耗/产生和对缺血应激的防御反应。